Literature DB >> 17576237

Dual effects of sodium lauryl sulphate on human oral epithelial structure.

Evelyn Neppelberg1, Daniela Elena Costea, Olav Karsten Vintermyr, Anne Christine Johannessen.   

Abstract

Sodium lauryl sulphate (SLS) is a common detergent known to cause irritation and inflammatory reactions in skin. SLS is also the most commonly used toothpaste detergent and has been related to intraoral adverse effects. However, its specific biological effects on the oral mucosa (OM) have not yet been identified. The objective of this study was to investigate the putative effects of SLS on human oral epithelium using a novel in vitro reconstructed three-dimensional cell culture model. Reconstructed human OM, generated from primary normal human oral keratinocytes and fibroblasts, was exposed to clinically relevant concentrations of SLS (range 0.015-1.5%). The cultured tissues were evaluated by histomorphometry, immunohistochemistry (Ki-67, epithelial (E)-cadherin, alpha6-, beta1-integrins, cleaved caspase-3) and the TUNEL method. Increased epithelial thickness, enhanced proliferation (Ki-67), a more pronounced expression of E-cadherin throughout all epithelial cell layers and single TUNEL-positive cells in the middle spinous cell layers were observed in cultures exposed to low concentrations (0.015%) of SLS. At exposure to higher SLS concentrations (>or=0.15%), epithelial thickness, cell proliferation and E-cadherin expression gradually decreased and in the central areas of exposed regions, cells detached from each other and underwent cell death. In conclusion, clinically relevant concentrations of SLS have dual effects on reconstituted human OM; although occasional cell death within the epithelium was also observed, the increased epithelial thickness, proliferation and E-cadherin expression induced at lower concentrations might be associated with a protective mucosal response, whereas at higher concentrations a more destructive type of reaction predominated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576237     DOI: 10.1111/j.1600-0625.2007.00567.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

1.  Modification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.

Authors:  Pauline D Scanlan; Anna M Bischofberger; Alex R Hall
Journal:  FEMS Microbiol Ecol       Date:  2016-10-12       Impact factor: 4.194

2.  Relationship between toothpastes properties and patient-reported discomfort: crossover study.

Authors:  Mariana Bruno; Fernando Taddeo; Igor Studart Medeiros; Letícia Cristina Cidreira Boaro; Maria Stella N A Moreira; Márcia Martins Marques; Fernanda Calabró Calheiros
Journal:  Clin Oral Investig       Date:  2015-07-31       Impact factor: 3.573

3.  Efficacy of various cleaning solutions on saliva-contaminated zirconia for improved resin bonding.

Authors:  Da-Hye Kim; Jun-Sik Son; Seong-Hwa Jeong; Young-Kyung Kim; Kyo-Han Kim; Tae-Yub Kwon
Journal:  J Adv Prosthodont       Date:  2015-04-23       Impact factor: 1.904

4.  Microfluidics-based skin irritation test using in vitro 3D angiogenesis platform.

Authors:  Norhana Jusoh; Jihoon Ko; Noo Li Jeon
Journal:  APL Bioeng       Date:  2019-07-29

5.  Cytotoxic effects of different detergent containing children's toothpastes on human gingival epithelial cells.

Authors:  Sinem Birant; Yazgul Duran; Tunc Akkoc; Figen Seymen
Journal:  BMC Oral Health       Date:  2022-03-09       Impact factor: 2.757

6.  In vitro reconstruction of human junctional and sulcular epithelium.

Authors:  G Dabija-Wolter; V Bakken; M R Cimpan; A C Johannessen; D E Costea
Journal:  J Oral Pathol Med       Date:  2012-09-05       Impact factor: 4.253

7.  Effects of Brazilian Propolis on Dental Plaque and Gingiva in Patients with Oral Cleft Malformation Treated with Multibracket and Removable Appliances: A Comparative Study.

Authors:  Agnieszka Machorowska-Pieniążek; Małgorzata Skucha-Nowak; Anna Mertas; Marta Tanasiewicz; Iwona Niedzielska; Tadeusz Morawiec; Stefan Baron
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-08       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.